Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis.

Pediatrics - 1 Aug 2012

Chung Carolyn S, Yamini Sedigheh, Trumbo Paula R

Abstract excerpt

In this review, we explain how the US Food and Drug Administration (FDA) used its evidence-based review system to evaluate the scientific evidence for a qualified health claim for 100% whey-protein partially hydrolyzed infant formula (W-PHF) and reduced risk of atopic dermatitis (AD). The labeling of health claims, including qualified health claims, on conventional foods and dietary supplements require premarket...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dermatitis, Atopic
Share to Endpoint Determination
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Food Safety

Share to Milk Proteins

Share to Randomized Controlled Trials as Topic

Share to United States

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 22778306
DOI: 10.1542/peds.2012-0333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis.PMID 22778306Read ↗

Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia.Semantic proximity Read ↗

Use of hypoallergenic formula in the prevention of atopic disease among Asian children.Semantic proximity Read ↗

Adverse Events Following Cow's Milk-Derived Human Milk Fortification: A Nationwide Human Milk Bank StudySemantic proximity Read ↗

Status of nutrition and health claims in Europe by mid 2015Semantic proximity Read ↗

Adverse reactions to cow's milk proteins.Semantic proximity Read ↗

Functionalization of bovine whey proteins by dietary phenolics from molecular-level fabrications and mixture-level combinationsSemantic proximity Read ↗

Human milk contains S100B proteinSemantic proximity Read ↗

Development and sensory evaluation of a high-protein, vitamin-fortified fruit roll-up for children with cystic fibrosisSemantic proximity Read ↗

Informing risk management for patients with cow’s milk allergy: Threshold dose distributions from a large population of cow’s milk allergy patients underwent very low dose food challengesSemantic proximity Read ↗

Strategies for the discovery, identification and validation of milk protein-derived bioactive peptidesSemantic proximity Read ↗

The new EC Regulation on nutrition and health claims on foodsSemantic proximity Read ↗

Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.